1. Pure Bioscience ( PURE)

Company Profile: Pure Bioscience develops bioscience products, including antimicrobials.

Altman Z-score: 69.8

Closing Price: $2.05 (Sept. 15)

Financial Metrics: Pure Bioscience has a price-to-book ratio of 11.9, which suggests the stock may be overvalued based on book value. Pure's quick ratio, which measures the ability to meet short-term obligations with its most liquid assets, is 4.9, indicating the company should be able to meet its current liabilities.

Analyst Consensus: Only one firm follows Pure Bioscience, recommending that investors buy shares of the bioscience products maker

-- Written by Robert Holmes in Boston.

>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet.

>To submit a news tip, send an email to: tips@thestreet.com.

READERS ALSO LIKE:



Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

5 Stocks Poised for Breakouts

4 Stocks Under $5 Ripping Higher

$5 Stocks Least Likely to Declare Bankruptcy

Palm, Star Scientific: Late Day Volume Plays

Palm, Star Scientific: Late Day Volume Plays